• Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock
Investing

Quantinuum opens 13% above IPO price, valuing quantum computing firm at $17.6B

by June 4, 2026
written by June 4, 2026

Quantinuum made a strong debut on the Nasdaq on Thursday, with shares opening at $68 apiece, 13% above their initial public offering price, in what investors viewed as a significant vote of confidence for the emerging quantum computing industry.

The company raised $1.68 billion in an upsized offering after pricing shares at $60 each, above its previously marketed range of $53 to $55.

At its opening trade price, Quantinuum was valued at roughly $17.6 billion.

The debut marks one of the most closely watched public listings in the quantum computing sector, an industry that has long promised transformative advances in computing power but has struggled to prove commercial viability.

A traditional route to public markets

Founded in 2021 through the merger of Honeywell’s quantum computing division and UK-based Cambridge Quantum, Quantinuum positions itself as a full-stack quantum computing platform that provides both hardware and software solutions.

Unlike several other quantum-computing companies that reached public markets through mergers with special-purpose acquisition companies, Quantinuum opted for a traditional IPO process.

Chief Executive Rajeeb Hazra said the decision reflected the company’s desire to build credibility in a sector where investors continue to scrutinize technological claims and commercial prospects.

The traditional listing route was chosen, he said, because Quantinuum wanted to demonstrate that there was “no air gap between what we’re saying and what we’re doing.”

The company’s successful offering also reflects growing investor willingness to back businesses developing next-generation computing technologies.

“You’re starting to see real revenue that’s coming from these companies, so it makes sense for them to start to go public,” Willy Lee, a principal at SuRo Capital, told MarketWatch.

Commercial adoption remains in early stages

According to its regulatory filings, Quantinuum serves customers across industries including pharmaceuticals, materials science, finance, government, and industrial markets.

Its customer roster includes companies such as JPMorgan Chase and Amgen.

“We have customers today that are using our commercially available hardware and software, our full stack, to get started with their quantum journey,” Hazra said in an interview with CNBC on Thursday.

Quantum computing relies on the principles of quantum mechanics to process information in ways that could eventually solve problems beyond the reach of conventional computers.

While practical adoption remains at an early stage, Hazra said demand for advanced computing resources is expected to grow significantly in the coming years.

He described the need for quantum computing capabilities as “absolutely a given,” even though widespread commercial deployment is still developing.

Government support boosts industry outlook

The sector received a boost last month when the US Department of Commerce announced preliminary agreements to provide $2 billion in funding and take equity stakes in nine companies involved in the country’s quantum ecosystem.

Quantinuum is expected to receive $100 million under the initiative, which is funded through the 2022 Chips and Science Act.

“It’s a great validation of quantum, of Quantinuum, as a strategic asset for the US quantum industry,” Hazra said, adding that the support would help advance trapped-ion quantum computing technology.

Financial challenges remain

Despite strong investor enthusiasm, Quantinuum’s financial results underscore the challenges facing many companies in the emerging technology sector.

The company reported that first-quarter revenue fell 73% year over year to $5.24 million from $19.1 million.

Net losses widened sharply to $136.5 million from $30.5 million in the same period a year earlier.

Honeywell is expected to retain a majority stake following the IPO and will continue to serve as both a strategic customer and partner, according to the company’s prospectus.

For investors, the listing represents a high-profile test of whether public markets are prepared to back quantum computing companies despite ongoing losses and long development timelines.

Thursday’s debut suggests that, for now, enthusiasm for the technology remains strong.

The post Quantinuum opens 13% above IPO price, valuing quantum computing firm at $17.6B appeared first on Invezz

0 comment
0
FacebookTwitterPinterestEmail

previous post
Why UnitedHealth stock is surging today?
next post
Dow hits record high as investors rotate out of AI chip stocks

related articles

UK equities hover at three-week lows as investors...

June 10, 2026

Rolls-Royce share price faces a crucial test: rally...

June 10, 2026

Asian tech stocks slide as AI rally loses...

June 10, 2026

Meta is building a new $20B business, Truist...

June 10, 2026

BYD chairman projects global leadership in five years...

June 10, 2026

Dow gains as Nasdaq slides on chip selloff,...

June 9, 2026

DraftKings stock jumps 11% as prediction markets volume...

June 9, 2026

Broadcom stock falls despite new AI data center...

June 9, 2026

Options data reveals how Oracle stock may respond...

June 9, 2026

Veeco stock soars on NSA500 order as chip...

June 9, 2026
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest News

  • GOP lawmaker warns voters that Platner’s ‘extreme’ policies just as concerning as his baggage: ‘Stay away’

    June 9, 2026
  • Quantinuum opens 13% above IPO price, valuing quantum computing firm at $17.6B

    June 4, 2026
  • Ciena stock sinks despite earnings beat as investors seek bigger AI upside

    June 4, 2026
  • Tesla stock is down around 1% on Thursday: what’s hurting the EV stock?

    June 4, 2026
  • Eli Lilly stock rises as Retatrutide data boosts obesity drug lead

    June 8, 2026

Popular Posts

  • 1

    Intel, AMD stocks slide again in aftermath of Broadcom’s weak outlook

    June 5, 2026
  • 2

    Dow tumbles 680 points as chip rout sends Nasdaq to biggest drop since 2025

    June 5, 2026
  • 3

    Wedbush makes a strong case for buying the dip in Planet Labs stock

    June 5, 2026
  • 4

    Dem senator bankrolling Platner’s campaign ripped for downplaying abuse allegations in bombshell report

    June 5, 2026
  • 5

    Wedbush makes a strong case for buying the dip in Planet Labs stock

    June 5, 2026

Categories

  • Editor's Pick (35)
  • Investing (105)
  • Stock (10)

Latest Posts

  • Broadcom stock falls despite new AI data center partnership

    June 9, 2026
  • GOP senators torch scandal-plagued Platner while Dems stay silent on candidacy

    June 5, 2026
  • Republicans face ticking midterm clock as Iran fallout keeps pressure on gas prices

    June 5, 2026

Recent Posts

  • Intel stock rallies on reports of foundry wins from Google and Nvidia

    June 8, 2026
  • GSK’s $10.6B Nuvalent takeover fails to impress investors as shares fall: here’s why

    June 9, 2026
  • Jensen Huang strikes again, recommends buying Qualcomm stock

    June 9, 2026

Editor’s Pick

  • Dow tumbles 680 points as chip rout sends Nasdaq to biggest drop since 2025

    June 5, 2026
  • Why UnitedHealth stock is surging today?

    June 4, 2026
  • Hong Kong financial stocks tumble as China tightens offshore checks

    June 5, 2026
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Disclaimer: moneyrisetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 moneyrisetoday.com | All Rights Reserved

Money Rise Today – Investing and Stock News
  • Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock